2 completed. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow Juan Badimon: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sotagliflozin in Heart Failure With Preserved Ejection Fraction (HFpEF) Patients Sotagliflozin, Placebo - Heart Failure With Preserved Ejection Fraction | Phase 4 | Completed | Juan Badimon | 88 | 2022-10-26 | 2026-06-24 |
| Platelet Sub-study of the TWILIGHT Trial Ticagrelor, ASA - Coronary Artery Disease, Myocardial Infarction | Completed | Juan Badimon | 40 | 2015-06-28 | 2020-02-26 |
Coronary Artery Disease (1) · Myocardial Infarction (1) · Thrombosis (1)
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol (1) · Ticagrelor (1)
United States (2)
Carlos G Santos-Gallego, MD (1) · Juan J Badimon (1)